Web Analytics

3 Latest Announced Rounds

  • $26,000,000
    Series B

    5 Investors

    Computer Hardware Manufacturing
    May 15th, 2026
  • Undisclosed Amount
    Seed

    1 Investors

    Food and Beverage Manufacturing
    May 15th, 2026
  • $8,300,000
    Seed

    6 Investors

    Software Development
    May 15th, 2026
$847.85M Raised in 38 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Phialogics - The immune tolerance company

start up
Germany - Frankfurt, Hesse
  • 08/05/2023
  • Pre-Seed
  • $662,970

Our immune checkpoint activators protect patient’s organ tissue.
Unique approach :
- Potential for BEST-in-class super agonist against immune-mediated tissue damage
- High selectivity for active T-cells
- Proof of concept in relevant human in vitro models and mouse model of disease


Related People

Andreas ErnstFounder

Andreas Ernst Germany - ND

Expert in protein engineering with a keen interest in drug development for the treatment of autoimmune diseases.